Erschienen in:
01.12.2011 | Letter
Robotic versus laparoscopic surgery for rectal cancer and cost-effectiveness analysis
verfasst von:
Christof Hottenrott
Erschienen in:
Surgical Endoscopy
|
Ausgabe 12/2011
Einloggen, um Zugang zu erhalten
Excerpt
Innovation in technology is crucial for improving healthcare. Robotic technology in surgical practice [
1] and next-generation sequencing (NGS) platforms in genomics research [
2] represent the most promising technological advances for improving clinical outcomes of patients with complex diseases such as cancer. However, technological innovation in healthcare is an important driver of cost growth. Very often, physicians and patients seeking the best treatment embrace new modes of treatment before there is evidence-based clinical utility of new medical devices. It is obvious that comparative-effectiveness research (CER) is required before new medical devices, diagnostics or novel drugs are incorporated into clinical practice [
3]. …